Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 1 10Phase 3 9Phase NA 8Phase 1/2 5Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Non-alcoholic Fatty Liver Disease 1Metabolic Syndrome 1Hirsutism 1Dyslipidemias 1Amenorrhea 1Acne Vulgaris 1

Interventions

Dexamethasone 13Saline Solution 8Bupivacaine 8Bevacizumab 8Tobacco Use Cessation Devices 7Specimen Handling 7Nivolumab 7Magnetic Resonance Spectroscopy 7Lenalidomide 7Fluorouracil 7pembrolizumab 6Rituximab 6Prednisone 6Letrozole 6Carboplatin 6Propofol 5Human Papillomavirus Recombinant Vaccine nonavalent 5trametinib 4lenvatinib 4dabrafenib 4cabozantinib 4anlotinib 4Trastuzumab 4Tamoxifen 4Standard of Care 4Sodium Chloride 4Ropivacaine 4Paclitaxel 4Immune Checkpoint Inhibitors 4Esomeprazole 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Metformin × 1 year × Clear all
NCT05680805 2025-09-19

Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 4 Active not recruiting
100 enrolled

Polycystic Ovary Syndrome

NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Columbia University

Phase 4 Terminated
3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡